Peter A. Thompson, M.D., has served as a member of our Board of Directors since the closing of the merger in November 2022. Dr. Thompson was a co-founder of Silverback Therapeutics, Inc., served as its Chair from 2016 to November 2022, and as its Chief Executive Officer from 2016 to April 2020. Dr. Thompson is a Member at OrbiMed Advisors LLC, an investment firm. Dr. Thompson currently serves on the boards of directors of several public companies including Alpine Immune Sciences Inc. (Nasdaq: ALPN) (since 2017), Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS) (since 2014), and Edgewise Therapeutics, Inc. (Nasdaq: EWTX) (since 2017), as well as several private companies. Previously, Dr. Thompson served on the boards of Decibel Therapeutics, Inc. (Nasdaq: DBTX), Janux Therapeutics, Inc. (Nasdaq: JANX), PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), Prevail Therapeutics Inc. (Nasdaq: PRVL), and Synthorx Inc. until its acquisition by Sanofi S.A. (formerly Nasdaq: THOR). Dr. Thompson also previously served in executive leadership roles at Trubion Pharmaceuticals, Inc., Chiron Corporation, and Becton, Dickinson and Company. Dr. Thompson is an Affiliate Professor of Neurosurgery at the University of Washington. In addition, Dr. Thompson holds numerous patents and is a board-certified internist and oncologist. Dr. Thompson holds a Sc. B. in Molecular Biology and Mathematics from Brown University and an M.D. from Brown University Medical School.
What is Peter A. Thompson's net worth?
The estimated net worth of Peter A. Thompson is at least $1.05 million as of August 23rd, 2024. Dr. Thompson owns 83,695 shares of ARS Pharmaceuticals stock worth more than $1,045,351 as of March 28th. This net worth evaluation does not reflect any other assets that Dr. Thompson may own. Learn More about Peter A. Thompson's net worth.
How do I contact Peter A. Thompson?
The corporate mailing address for Dr. Thompson and other ARS Pharmaceuticals executives is 500 Fairview Ave N Suite 600, Seattle WA, 98109. ARS Pharmaceuticals can also be reached via phone at 206-456-2900 and via email at ir@silverbacktx.com. Learn More on Peter A. Thompson's contact information.
Has Peter A. Thompson been buying or selling shares of ARS Pharmaceuticals?
Peter A. Thompson has not been actively trading shares of ARS Pharmaceuticals within the last three months. Most recently, Peter A. Thompson sold 83,695 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $13.00, for a transaction totalling $1,088,035.00. Learn More on Peter A. Thompson's trading history.
Who are ARS Pharmaceuticals' active insiders?
Are insiders buying or selling shares of ARS Pharmaceuticals?
In the last twelve months, insiders at the sold shares 37 times. They sold a total of 2,961,053 shares worth more than $39,496,274.18. The most recent insider tranaction occured on March, 20th when insider Eric Karas sold 10,000 shares worth more than $140,000.00. Insiders at ARS Pharmaceuticals own 40.1% of the company.
Learn More about insider trades at ARS Pharmaceuticals. Information on this page was last updated on 3/20/2025.
